Cargando…
Endothelial to Mesenchymal Transition in Pulmonary Vascular Diseases
Lung diseases, such as pulmonary hypertension and pulmonary fibrosis, are life-threatening diseases and have common features of vascular remodeling. During progression, extracellular matrix protein deposition and dysregulation of proteolytic enzymes occurs, which results in vascular stiffness and dy...
Autores principales: | Yun, Eunsik, Kook, Yunjin, Yoo, Kyung Hyun, Kim, Keun Il, Lee, Myeong-Sok, Kim, Jongmin, Lee, Aram |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7767472/ https://www.ncbi.nlm.nih.gov/pubmed/33371458 http://dx.doi.org/10.3390/biomedicines8120639 |
Ejemplares similares
-
Ginsenoside Rg3 attenuates pulmonary fibrosis by inhibiting endothelial to mesenchymal transition
por: Yun, Eunsik, et al.
Publicado: (2023) -
Endothelial to Mesenchymal Transition Represents a Key Link in the Interaction between Inflammation and Endothelial Dysfunction
por: Cho, Jin Gu, et al.
Publicado: (2018) -
Ginsenoside Rg3 protects against iE-DAP–induced endothelial-to-mesenchymal transition by regulating the miR-139-5p–NF-κB axis
por: Lee, Aram, et al.
Publicado: (2020) -
MicroRNAs as critical regulators of the endothelial to mesenchymal transition in vascular biology
por: Kim, Jongmin
Publicado: (2018) -
Endothelial miR-26a regulates VEGF-Nogo-B receptor-mediated angiogenesis
por: Jo, Ha-neul, et al.
Publicado: (2017)